Unlocking the Future of Immune Research with PBMCs

Peripheral Blood Mononuclear Cells (PBMCs) are at the heart of today’s most exciting medical breakthroughs. These immune cells—T cells, B cells, NK cells, and monocytes—are easily isolated from peripheral blood and provide a powerful window into the human immune system. Due to their close representation of immune status, PBMCs have become a fundamental model in immunology, oncology, infectious disease, and regenerative medicine research.

What’s New in PBMC Research?

Recent investigations continue to highlight the versatility and translational potential of PBMCs:

- Functional Immunophenotyping with Mass Cytometry (CyTOF)
Peripheral blood mononuclear cells can now be interrogated across dozens of surface and intracellular markers simultaneously using CyTOF. This high-resolution approach enables comprehensive mapping of immune cell heterogeneity, facilitates the identification of novel biomarkers, and accelerates the development of immunological models relevant to human disease.

- PBMC-Based Immunotherapies
Early-phase clinical trials are evaluating specific PBMC cell types as components of personalized immunotherapeutic strategies, including applications in pediatric cancers such as neuroblastoma. These studies underscore the potential of patient-derived mononuclear cells to contribute directly to next-generation, precision-tailored cancer treatments.

- Global Studies Without Borders
Evidence indicates that PBMCs maintain functional integrity even after overnight shipment at ambient temperature, greatly reducing logistical constraints. This robustness supports the expansion of large-scale, multicenter, and international research collaborations by simplifying sample acquisition and distribution.

AcceGen: Your Source for Diverse PBMC Solutions

At AcceGen, we go beyond standard offerings by providing one of the most comprehensive PBMC portfolios available:

- Human PBMCs
Available from both healthy donors and individuals with autoimmune, infectious, oncological, or metabolic disorders. These samples provide robust platforms for comparative immune profiling, therapeutic discovery, and biomarker validation.

- Animal PBMCs
Including rabbit PBMCs, beagle PBMCs, and rhesus monkey PBMCs, , which serve as critical resources for preclinical evaluation, cross-species immunology, and translational studies that bridge experimental findings to clinical application.

Each batch is ethically sourced and subjected to stringent quality control, ensuring high viability, purity, and consistency. Offered in cryopreserved formats, AcceGen PBMCs are optimized for downstream applications such as flow cytometry, CyTOF, transcriptomic analysis, cytokine profiling, and functional T-cell assays.

Why It Matters

From oncology and immunotherapy to infectious disease modeling, vaccine development, and multi-omics biomarker discovery, PBMCs are accelerating breakthroughs across today’s most critical research frontiers.

With AcceGen’s extensive portfolio of human and animal PBMCs—including rabbit, beagle, rat, and rhesus monkey PBMC options, researchers gain the flexibility, quality, and diversity required to advance discovery and translation with confidence.

Stay at the forefront of immune research—explore the latest PBMC applications and partner with AcceGen to transform your scientific vision into impact.

PBMCs: Driving the Future of Immune Research

Peripheral Blood Mononuclear Cells (PBMCs) are the key to unlocking breakthroughs in immunology, oncology, infectious disease, and regenerative medicine.

At AcceGen, we provide a wide portfolio of human (healthy and disease-state donors) and animal PBMCs (rabbit, beagle, rhesus monkey). Each batch is ethically sourced and rigorously tested for high viability, purity, and reproducibility—optimized for applications in flow cytometry, CyTOF, biomarker discovery, and immunotherapy development.

Advance your research with PBMCs that deliver consistency, flexibility, and innovation.
AcceGen — Empowering Discovery, Accelerating Science.

Explore more